Clinical Trials Browser

Interventional × Carcinoma, Hepatocellular × penpulimab × Clear all

NCT07075419 2025-07-20

JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure

Phase 1/2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05862337 2023-05-17

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular